Stratistics MRC에 따르면 세계의 수면 보조제 시장은 2025년에 691억 7,000만 달러를 차지하고, 예측 기간 동안 CAGR은 7.98%를 나타내며, 2032년에는 1,183억 8,000만 달러에 이를 것으로 예상됩니다.
수면 유지, 또는 더 나은 수면을 얻기위한 약제, 처방약 또는 가정용 약은 수면 보조제로 알려져 있습니다. 입제는 스트레스, 시차 흐림, 수면 사이클의 불규칙성 등으로 인한 일시적인 수면장애의 치료에 자주 사용됩니다.
수면장애 증가
불면증, 수면 무호흡 증후군, 레스트레스 레그스 증후군 등의 질환이 증가하고 있는 것은 수면 위생 상태의 악화, 앉기 쉬운 라이프 스타일, 스트레스가 원인이 되고 있습니다. 침대, 수면 보조제, 수면 모니터 장치 등 수요가 증가하고 있습니다. 또한 수면 보조제를 추천하는 건강 관리 전문가도 늘어나고 있으며, 이것이 시장 확대의 원동력이 되고 있습니다.
수면제의 부작용과 의존성
수면제의 매력은 현기증, 낮 동안의 졸음, 인지 장애 등 많은 호소에 의해 저하되고 있습니다. 증가 이러한 위험에 대한 인식이 높아짐에 따라 환자와 건강 관리 전문가는 비 약리학 대체품을 사용하기 시작했습니다.
비약리적이고 자연적인 솔루션에 대한 수요 증가
종속성과 악영향을 우려하여 기존의 의약품보다 안전하고 홀리스틱한 대체품을 요구하는 소비자가 늘고 있습니다. 또한 수면 위생의 개선과 생활 습관의 개선을 장려하는 웰빙 동향에 의해 시장이 확대되고 있습니다.
엄격한 규제 체제와 제품 회수
규제 당국이 정한 엄격한 안전과 효능 요건은 새로운 기업이 최첨단 제품을 도입하는 것을 어렵게 하고 있습니다. 평판은 안전에 대한 우려로 인한 빈번한 제품 회수에 의해 손상됩니다.
COVID-19의 영향
COVID-19의 대유행은 수면 보조제 시장에 큰 영향을 주어 스트레스와 불안의 증대, 일상생활의 혼란에 의한 수요 증가로 이어졌습니다. 텔레헬스의 확대도, 처방전이 들어가는 수면 보조제에의 액세스를 용이하게 했습니다.초기에는 공급 체인의 혼란이 제품의 입수성에 영향을 미쳤습니다만, 팬데믹의 발생중과 그 후에 수면의 건강과 정신적인 건강에 대한 의식이 높아졌습니다.
예측기간 동안 약수처리 분야가 최대가 될 전망
불면증과 다른 수면장애로 고통받는 사람들에게 효과적인 구제로 인해 예측 기간 동안 약수처리 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 보다 안전하고 습관성이 없는 의약품의 도입이 시장의 성장을 더욱 뒷받침하고 있습니다.
예측 기간 동안 수면 클리닉 분야의 CAGR이 가장 높아질 전망
예측 기간 동안 수면 클리닉 분야는 가장 높은 성장률을 보일 것으로 예상됩니다. 세계적으로 수면장애의 증례가 증가하고 있기 때문에 이러한 전문 시설을 통해 전문가의 도움을 요구하는 환자가 증가하고 있습니다. 또, 수면 클리닉은 선진적인 모니터링·진단 기술의 사용을 추진하고 있어 시장의 기술 혁신에 박차를 가하고 있습니다.
예측 기간 동안 스트레스 수준과 수면 무호흡 증후군 증가로 아시아태평양이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 수면 보조제에 대한 수요를 촉진하고 있습니다. 중국, 인도, 일본 등 국가들은 의료 인프라의 확대와 가처분소득 증가로 주요 공헌국이 되고 있습니다.
예측 기간 동안 북미는 스트레스 관련 질병으로 인해 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 기술의 진보와 의료 지출 증가가 성장을 더욱 뒷받침하고 있습니다.
According to Stratistics MRC, the Global Sleep Aids Market is accounted for $69.17 billion in 2025 and is expected to reach $118.38 billion by 2032 growing at a CAGR of 7.98% during the forecast period. Drugs, prescription drugs, or home remedies that help people fall asleep, stay asleep, or get better sleep are known as sleep aids. These consist of prescription pharmaceuticals, herbal supplements, over-the-counter medications and items based on melatonin. Sleep aids are frequently used to treat temporary sleep difficulties brought on by stress, jet lag, or inconsistent sleep cycles. Some function by regulating the body's sleep-wake cycle, while others relax the neurological system.
Rising prevalence of sleep disorders
Poor sleep hygiene, sedentary lifestyles, and stress are contributing to the rise in conditions like insomnia, sleep apnoea, and restless legs syndrome. As knowledge increases, more people are looking for both non-medical and medical ways to enhance the quality of their sleep. The demand for goods like beds, sleep aids, and sleep monitoring equipment has increased as a result. Additionally, more healthcare professionals are recommending sleep aids, which is driving the market's expansion. As a result, the market for sleep aids is increasing quickly to satisfy the rising need for efficient sleep aids.
Side effects and dependence on sleep medications
The allure of these medications is diminished by the numerous complaints of dizziness, daytime sleepiness, and cognitive impairments. Overuse frequently results in tolerance, necessitating greater dosages to achieve the same results. This raises the possibility of addiction and the symptoms of withdrawal. Patients and healthcare professionals are increasingly using non-pharmacological alternatives as awareness of these hazards increases. As a result, consumer confidence in prescription sleep aids is eroding, which is impeding market growth.
Growth in demand for non-pharmacological and natural solutions
A growing number of consumers are looking for safer, more holistic alternatives to conventional pharmaceuticals because they are worried about dependency and negative effects. As a result of this change, herbal supplements, meditation applications, and cognitive behavioural treatment for insomnia (CBT-I) have become increasingly popular. Health-conscious people are increasingly using natural sleep aids including essential oils, valerian root, and melatonin. Furthermore, the market is expanding due to wellness trends that encourage improved sleep hygiene and lifestyle changes. The need for these safe and long-lasting remedies is only increasing as people realise how important restorative sleep is.
Stringent regulatory framework and product recalls
Strict safety and efficacy requirements set by regulatory agencies make it difficult for new companies to introduce cutting-edge goods. The availability of some common chemicals used in sleep aids is likewise restricted by these rules. Consumer confidence and brand reputation are harmed by frequent product recalls brought on by safety concerns. Recalls also cause supply chain disruptions and monetary losses. When combined, these factors deter investment in sleep aid developments and slow down market growth.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the sleep aids market, leading to increased demand due to heightened stress, anxiety, and disrupted daily routines. Lockdowns and health concerns triggered widespread sleep disturbances, pushing consumers to seek over-the-counter sleep solutions, herbal supplements, and sleep tech devices. Telehealth expansion also facilitated easier access to prescription sleep aids. While supply chain disruptions initially affected product availability, the overall market witnessed growth as awareness of sleep health and mental well-being gained importance during and after the pandemic.
The medications segment is expected to be the largest during the forecast period
The medications segment is expected to account for the largest market share during the forecast period, due to effective relief for individuals suffering from insomnia and other sleep disorders. Rising stress levels, anxiety, and mental health issues have led to increased demand for prescription and over-the-counter sleep medications. Pharmaceutical innovations and the introduction of safer, non-habit-forming drugs further boost market growth. The ease of availability and physician recommendations also drive consumer preference toward medications. Additionally, the aging population, prone to sleep disturbances, contributes to higher medication consumption, fueling overall market expansion.
The sleep clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the sleep clinics segment is predicted to witness the highest growth rate, due to by providing accurate diagnosis and personalized treatment for sleep disorders. These clinics increase awareness about conditions like insomnia, sleep apnea, and restless leg syndrome, boosting demand for therapeutic devices and medications. With rising cases of sleep disorders globally, more patients are seeking professional help through these specialized facilities. Sleep clinics also promote the use of advanced monitoring and diagnostic technologies, fueling innovation in the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increased stress levels and sleep apnea. Greater awareness about mental health, changing lifestyles, and growing elderly populations are fueling demand for sleep aid products such as mattresses, pillows, sleep apnea devices, and OTC medications. Countries like China, India, and Japan are key contributors, with expanding healthcare infrastructure and rising disposable incomes. Technological advancements in sleep monitoring devices also boost the market, making Asia Pacific a major emerging hub for sleep aid solutions.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to stress-related disorders. Increasing awareness about the importance of quality sleep and the availability of a wide range of products such as medications, mattresses, sleep labs, and wearables contribute to market expansion. Technological advancements and growing healthcare spending further support growth. The U.S. leads the region due to high diagnosis rates and advanced healthcare infrastructure. Consumer preference for non-prescription and natural sleep solutions is also shaping market trends.
Key players in the market
Some of the key players profiled in the Sleep Aids Market include Koninklijke Philips N.V., ResMed Inc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc (GSK), Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cadwell Industries, Inc., Medtronic plc, Compumedics Limited, Natus Medical Incorporated, SomnoMed Ltd., Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare, Sleep Number Corporation, Serta Simmons Bedding, LLC and Zydus Lifesciences Ltd.
In February 2024, ResMed extended its collaboration with EnsoData, a provider of AI-driven sleep scoring software. This partnership enables more efficient diagnosis and treatment of sleep disorders through machine learning and digital health platforms.
In August 2023, Philips expanded its manufacturing capabilities in India to include a broader range of Personal Health products. The company enhanced production at its co-manufacturing site in Baddi, Himachal Pradesh, to produce mother and childcare products alongside existing beauty and grooming items.
In July 2023, ResMed acquired Somnoware, a U.S.-based sleep and respiratory care diagnostics software company. The move strengthens ResMed's digital health ecosystem and enhances its support for physicians in managing patients with sleep apnea and other respiratory conditions.